Rhumbline Advisers Sells 3,244 Shares of Waldencast plc (NASDAQ:WALD)

Rhumbline Advisers trimmed its stake in Waldencast plc (NASDAQ:WALD) by 5.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 53,479 shares of the company’s stock after selling 3,244 shares during the quarter. Rhumbline Advisers’ holdings in Waldencast were worth $215,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of WALD. Point72 Asia Singapore Pte. Ltd. grew its stake in Waldencast by 293.9% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company’s stock valued at $25,000 after purchasing an additional 5,114 shares in the last quarter. Barclays PLC boosted its stake in shares of Waldencast by 301.4% during the 3rd quarter. Barclays PLC now owns 32,436 shares of the company’s stock worth $117,000 after acquiring an additional 24,355 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Waldencast by 52.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 43,250 shares of the company’s stock worth $157,000 after acquiring an additional 14,803 shares during the period. SG Americas Securities LLC bought a new position in shares of Waldencast during the 4th quarter worth approximately $42,000. Finally, Catalina Capital Group LLC boosted its stake in shares of Waldencast by 69.9% during the 4th quarter. Catalina Capital Group LLC now owns 27,102 shares of the company’s stock worth $109,000 after acquiring an additional 11,154 shares during the period. 41.97% of the stock is currently owned by institutional investors.

Waldencast Trading Down 5.2 %

Waldencast stock opened at $3.12 on Tuesday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78. Waldencast plc has a 52 week low of $2.41 and a 52 week high of $7.54. The stock has a fifty day moving average of $3.29 and a 200-day moving average of $3.47.

Analysts Set New Price Targets

Several brokerages have recently commented on WALD. Telsey Advisory Group reiterated an “outperform” rating and set a $6.00 target price on shares of Waldencast in a research note on Monday, November 18th. Canaccord Genuity Group boosted their price target on Waldencast from $5.00 to $6.00 and gave the company a “buy” rating in a research note on Friday, November 22nd. DA Davidson boosted their price target on Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a research note on Wednesday, December 4th. Finally, TD Cowen started coverage on Waldencast in a research note on Monday, December 16th. They issued a “hold” rating and a $4.30 price target for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $5.76.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.